• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Early menarche and later menopause are associated with increased ovarian cancer risk

bySiwen Liu, MScandSimon Pan, MD
February 13, 2026
in Chronic Disease, Obstetrics, Oncology
Reading Time: 2 mins read
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Share on FacebookShare on TwitterShare on LinkedIn

1. Across the premenopausal and postmenopausal groups, early menarche, later menopause, and longer reproductive span were associated with higher ovarian cancer risk, while parity was associated with lower risk of ovarian cancer. 

Evidence Rating Level: 2 (Good)

Although reproductive factors have been associated with ovarian cancer risk, it is unclear whether reproductive factor associations differ by menopausal status and birth cohorts. This study thus assessed the associations between reproductive factors and ovarian cancer risk across menopausal status and birth cohorts. This population-based cohort study used data from South Korea’s National Health Insurance Service (NHIS). Women aged >40 years who underwent NHIS health screening in 2009 were included and followed up until ovarian cancer diagnosis, death, or December 31, 2022. The primary outcome was incident ovarian cancer. In total, 2,285,774 women (932,637 [40.8%] premenopausal, 1, 353,137 [59.2%] postmenopausal; mean [SD] age, 54.9 [10.85] years) were included in the study. Over a mean (SD) follow-up duration of 10.7 (2.99) years, 10,729 ovarian cancer cases were identified. For both premenopausal women and postmenopausal women, early menarche (aged ≤12 vs >16 years) was associated with higher ovarian cancer risk (HR, 1.37; 95% CI, 1.16-1.61] and HR, 1.24; 95% CI, 1.00-1.54), while parity of >2 births was associated with lower ovarian cancer risk (HR, 0.68; 95% CI, 0.58-0.79 and HR, 0.71; 95% CI, 0.60-0.85]). Breastfeeding for >12 months and oral contraceptive use for >1 year were associated with lower ovarian cancer risk in premenopausal women (HR, 0.86; 95% CI, 0.77-0.96 and HR, 0.75; 95% CI, 0.61-0.93) but not postmenopausal women. Among postmenopausal women, later menopause (≥55 years; HR, 1.36; 95% CI, 1.11-1.66), longer reproductive span (≥40 years; HR, 1.21; 95% CI, 1.09-1.34), and hormone replacement therapy use for 2 to 5 years (HR, 1.20; 95% CI, 1.07-1.34) were associated with higher risk of ovarian cancer. Overall, this study found associations between reproductive factors and cancer risk that differed across menopausal status and birth cohorts, highlighting the need for tailored prevention interventions for these populations. 

Click here to read this study in JAMA Network Open

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Tags: gynecologic oncologygynecologymenarchemenopauseovarian cancer
Previous Post

A telephone-based intervention reduced loneliness and improved well-being among older adults

Next Post

2 Minute Medicine Rewind February 16, 2026

RelatedReports

An illustration showing a brain scan alongside a human brain, symbolizing brain health and cognitive decline.
Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
A collage illustrating the urinary bladder, immune system elements, cancer cells, and an IV bag, highlighting immunotherapy for urothelial cancer.
Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026
Surgical outcomes collage: an operating lamp above a steel tray of scalpel, forceps and scissors beside a folded drape
Chronic Disease

Surgery is associated with an increased quality of life in women with endometriosis

August 11, 2026
Uterine fibroids collage: an engraved uterus with tubes, ovaries and one small fibroid, a magnolia and a hot-water bottle
Chronic Disease

Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization

August 5, 2026
Next Post
Weekly research roundup collage: a young man in glasses and a crewneck sweater beside a stack of blank books and a coffee cup

2 Minute Medicine Rewind February 16, 2026

Febrile seizure collage: a plush bear on a soft blanket, a thermometer, a blank stopwatch and an engraved brain

Deep-learning models displayed expert-level accuracy in detecting epileptiform discharges on electroencephalogram (EEG) recordings

Weight-loss medicines and endometrial cancer collage: an engraved uterus with tubes and ovaries, an injection pen, a magnolia

Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer
  • AI health chatbot shows no benefit for perinatal anxiety or depression
  • ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.